Focus Care Pharmaceuticals B.V.
↗Zaandam, Netherlands
Focus Care Pharmaceuticals B.V. is a Dutch pharmaceutical company that specializes in the distribution and marketing of generic medicines and medical devices within the Netherlands. The company's primary mission is to enhance the affordability and accessibility of healthcare by providing high-quality generic alternatives to brand-name medications.
Rather than maintaining in-house manufacturing facilities, Focus Care leverages an extensive international network of trusted manufacturing partners. Their portfolio includes a wide range of generic drugs across various therapeutic areas, as well as specialized medical devices such as the AeroChamber Plus Flow-Vu and their proprietary non-pharmacological treatment for Restless Legs Syndrome (RLS), marketed under the brand Relegs.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Generic Pharmaceuticals & Medical Devices
SIZE & FINANCIALS
Employees:1-50
Revenue:$10M-$50M
Founded:2006
Ownership:private
Status:operating
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule, Medical Device
Active Trials:1
Trial Phases:Phase 4: 1
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Axxelent Pharma Science (Strategic collaboration for generic product development), Trudell Medical International (Distribution of AeroChamber Plus Flow-Vu), Cipla (Manufacturing partner for various generic brands like Vincion)
COMPETITION
Position:Niche Player
Competitors:Teva Nederland B.V., Sandoz B.V., Viatris (Mylan), Aurobindo Pharma B.V., Noctrix Health (Competitor in RLS device space)
LEADERSHIP
Key Executives:
Maurits Haasnoot - Owner and CEO
Carola Fockens - Generics Commercial Director
Erik - Director of Pharmaceutical Affairs
Scientific Founders:John van der Sluijs
LINKS
Website:focuscare.nl
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Focus Care Pharmaceuticals B.V.. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.